Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
This trial is in high risk patients to determine the safety, tolerance and efficacy of
posaconazole (POZ) vs. fluconazole in the prophylaxis against development of invasive fungal
infections (IFI).